Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 3/20 | 0.46 |
| ▸ | DPP4 | P27487 | 1/20 | 0.37 |
| ▸ | PREP | P48147 | 1/20 | 0.37 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.37 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.37 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24909162 | 1.00 | AR (0.46) | ARDPP4PREPDPP8DPP9 | |
| SCHEMBL24908826 | 1.00 | AR (0.46) | ARDPP4PREPDPP8DPP9 | |
| SCHEMBL24909258 | 1.00 | AR (0.46) | ARDPP4PREPDPP8DPP9 | |
| SCHEMBL24908824 | 1.00 | AR (0.46) | ARDPP4PREPDPP8DPP9 | |
| SCHEMBL24908827 | 1.00 | AR (0.46) | ARDPP4PREPDPP8DPP9 | |
| SCHEMBL24908825 | 1.00 | AR (0.46) | ARDPP4PREPDPP8DPP9 | |
| SCHEMBL24909261 | 0.89 | AR (0.44) | AR | |
| SCHEMBL24909241 | 0.89 | AR (0.60) | AR | |
| SCHEMBL24909152 | 0.89 | AR (0.60) | AR | |
| SCHEMBL24909153 | 0.89 | AR (0.60) | AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230012570-A1 | BICYCLIC COMPOUND USED AS SELECTIVE ANDROGEN RECEPTOR MODULATOR | MEDSHINE DISCOVERY INC. (CN) | 2023-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230012570-A1 | BICYCLIC COMPOUND USED AS SELECTIVE ANDROGEN RECEPTOR MODULATOR | AR, NR5A1, CYP17A1 | AR 1/4885DPP4 3382/4885PREP 3801/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.